Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction-Reference-Cited by-同舟云学术

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Published:2015-11-02 Issue:1 Volume:17 Page:95-103
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Zhao Ende,Maj Tomasz,Kryczek Ilona,Li Wei,Wu Ke,Zhao Lili,Wei Shuang,Crespo Joel,Wan Shanshan,Vatan Linda,Szeliga Wojciech,Shao Irene,Wang Yin,Liu Yan,Varambally Sooryanarayana,Chinnaiyan Arul M,Welling Theodore H,Marquez Victor,Kotarski Jan,Wang Hongbo,Wang Zehua,Zhang Yi,Liu Rebecca,Wang Guobin,Zou Weiping

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3313.pdf

Reference50 articles.

1. Ladell, K. et al. A molecular basis for the control of preimmune escape variants by HIV–specific CD8+ T cells. Immunity 38, 425–436 (2013).

2. Almeida, J.R. et al. Superior control of HIV–1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204, 2473–2485 (2007).

3. Harari, A. et al. An HIV–1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205, 63–77 (2008).

4. Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119–3131 (2008).

5. Precopio, M.L. et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses. J. Exp. Med. 204, 1405–1416 (2007).

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma;Translational Oncology;2024-11

2. A multifunctional nutrient transfer nanoCRISPR scaffold induces metabolic remodeling to fuel cancer immunotherapy;Nano Today;2024-10

3. Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key;Frontiers in Immunology;2024-09-13

4. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective;eBioMedicine;2024-09

5. Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09